TABITHA SATCHER: Open Payments
NPI 1558043992 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 36 payments from 11 companies in 2025. Trend: 2023 $23 · 2024 $772 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $163 |
| Novartis Pharmaceuticals Corporation | 5 | $141 |
| CVRx, Inc. | 2 | $125 |
| Novo Nordisk Inc | 5 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| Amgen Inc. | 3 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Recor Medical Inc | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: Kerendia, LEQVIO, Barostim Neo System, Wegovy, JARDIANCE, REPATHA, ONPATTRO, NEXLETOL.
Industry payments across SC — which companies pay providers there.
